1 |
Zhong Z , Dai L , Wu Q , Gao Y , Pu Y , Su G , Lu X , Zhang F , Tang C , Wang Y , Zhou C , Yang P . A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease. Nat Commun, 2023, 14: 3768.
doi: 10.1038/s41467-023-39483-5
|
2 |
Lueck CJ . Vogt-Koyanagi-Harada syndrome: what neurologists need to know. Pract Neurol, 2019, 19: 278- 281.
doi: 10.1136/practneurol-2018-002165
|
3 |
Rao NA , Sukavatcharin S , Tsai JH . Vogt-Koyanagi-Harada disease diagnostic criteria. Int Ophthalmol, 2007, 27 (2/3): 195- 199.
|
4 |
Ellul M , Solomon T . Acute encephalitis: diagnosis and management. Clin Med (Lond), 2018, 18: 155- 159.
|
5 |
Fitch MT , van de Beek D . Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis, 2007, 7: 191- 200.
doi: 10.1016/S1473-3099(07)70050-6
|
6 |
Du L , Kijlstra A , Yang P . Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res, 2016, 52: 84- 111.
doi: 10.1016/j.preteyeres.2016.02.002
|
7 |
Yang P , Zhong Z , Du L , Li F , Chen Z , Zhu Y , Zhang W , Huang F , Ye X , Su G , Kijlstra A . Prevalence and clinical features of systemic diseases in Chinese patients with uveitis. Br J Ophthalmol, 2021, 105: 75- 82.
doi: 10.1136/bjophthalmol-2020-315960
|
8 |
Hao T , Yang LI , Li B , Chen X , Li D , Liu X . Epidemiology of 2000 Chinese uveitis patients from northeast China. Br J Ophthalmol, 2021, 105: 317- 321.
doi: 10.1136/bjophthalmol-2020-316256
|
9 |
Urzua CA , Herbort CP Jr , Takeuchi M , Schlaen A , Concha-Del-Rio LE , Usui Y , Cuitino L , Papasavvas I . Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management. A brief review. J Ophthalmic Inflamm Infect, 2022, 12: 17.
doi: 10.1186/s12348-022-00293-3
|
10 |
Sonoda KH , Hasegawa E , Namba K , Okada AA , Ohguro N , Goto H , JOIS (Japanese Ocular Inflammation Society) Uveitis Survey Working Group . Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol, 2021, 65: 184- 190.
doi: 10.1007/s10384-020-00809-1
|
11 |
Ocular Immunology Group, Ophthalmology Branch, Chinese Medical Association , Uveitis and Ocular Immunology Group, Ophthalmologist Branch, Chinese Medical Doctor Association . Chinese expert consensus on the clinical diagnosis and treatment of Vogt-Koyanagi-Harada syndrome (2023). Zhonghua Yan Ke Za Zhi, 2023, 59: 518- 525.
doi: 10.3760/cma.j.cn112142-20230313-00098
|
|
中华医学会眼科学分会眼免疫学组, 中国医师协会眼科医师分会葡萄膜炎与免疫学组. 中国福格特-小柳-原田综合征临床诊疗专家共识(2023年). 中华眼科杂志, 2023, 59: 518- 525.
doi: 10.3760/cma.j.cn112142-20230313-00098
|
12 |
Marquezan MC , Nascimento H , Dalbem D , Muccioli C , Belfort R . Vogt-Koyanagi-Harada syndrome in Brazilian children. Ocul Immunol Inflamm, 2020, 28: 402- 408.
doi: 10.1080/09273948.2019.1588982
|
13 |
Tao QQ , Zhang XY , Yang FH , Liu Z , Li XR , Zhang XM . Analysis of clinical characteristics and genetic susceptibility of steroid-induced ocular hypertension in patients with uveitis. Zhonghua Yan Di Bing Za Zhi, 2022, 38: 353- 358.
doi: 10.3760/cma.j.cn511434-20220119-00040
|
|
陶清沁, 张歆怡, 杨付花, 刘峥, 李筱荣, 张晓敏. 葡萄膜炎患者继发糖皮质激素性高眼压临床特点分析及遗传易感性研究. 中华眼底病杂志, 2022, 38: 353- 358.
doi: 10.3760/cma.j.cn511434-20220119-00040
|
14 |
Yang P . Atlas of uveitis: diagnosis and treatment. Beijing: People's Medical Publishing House, 2021: 145- 533.
|
15 |
Goldgeier MH , Klein LE , Klein-Angerer S , Moellmann G , Nordlund JJ . The distribution of melanocytes in the leptomeninges of the human brain. J Invest Dermatol, 1984, 82: 235- 238.
doi: 10.1111/1523-1747.ep12260111
|
16 |
Greco A , Fusconi M , Gallo A , Turchetta R , Marinelli C , Macri GF , De Virgilio A , de Vincentiis M . Vogt-Koyanagi-Harada syndrome. Autoimmun Rev, 2013, 12: 1033- 1038.
doi: 10.1016/j.autrev.2013.01.004
|
17 |
Yang P , Zhong Y , Du L , Chi W , Chen L , Zhang R , Zhang M , Wang H , Lu H , Yang L , Zhuang W , Yang Y , Xing L , Feng L , Jiang Z , Zhang X , Wang Y , Zhong H , Jiang L , Zhao C , Li F , Cao S , Liu X , Chen X , Shi Y , Zhao W , Kijlstra A . Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol, 2018, 136: 1025- 1031.
doi: 10.1001/jamaophthalmol.2018.2664
|
18 |
Standardization of Uveitis Nomenclature (SUN) Working Group . Classification criteria for Vogt-Koyanagi-Harada disease. Am J Ophthalmol, 2021, 228: 205- 211.
doi: 10.1016/j.ajo.2021.03.036
|
19 |
Wu J , Pang S , Guo X , Peng W , Lin D , Dai M , Liu R , Wang Y . Comparison of the three sets of diagnostic criteria for Vogt-Koyanagi-Harada disease in southeast China: a retrospective case-control study. Ocul Immunol Inflamm, 2022,
|
20 |
Toudou-Daouda M , Ibrahim-Mamadou AK . Unusual neurologic manifestations of Vogt-Koyanagi-Harada disease: a systematic literature review. BMC Neurol, 2022, 22: 44.
doi: 10.1186/s12883-022-02569-6
|
21 |
Kira J . Vogt-Koyanagi-Harada disease and polymorphonuclear leuokocyts pleocytosis in cerebrospinal fluid. Intern Med, 2006, 45: 839- 840.
doi: 10.2169/internalmedicine.45.0160
|
22 |
Nitta E , Takamori M . Wallenberg's syndrome in a case of Vogt-Koyanagi-Harada disease. Rinsho Shinkeigaku, 1989, 29: 505- 508.
|
23 |
Ikeda M , Tsukagoshi H . Vogt-Koyanagi-Harada disease presenting meningoencephalitis: report of a case with magnetic resonance imaging. Eur Neurol, 1992, 32: 83- 85.
doi: 10.1159/000116797
|
24 |
Yu D , Kim TU , Chang MC . Delayed diagnosis of myelitis in a patient with Vogt-Koyanagi-Harada disease: a case report. J Int Med Res, 2021, 49: 3000605211001633.
|
25 |
Le TA , Simon S , Gilhotra J , Hissaria P . Vogt-Koyanagi-Harada syndrome presenting with bilateral optic disc swelling and leptomeningeal enhancement. BMJ Case Rep, 2019, 12: e229719.
doi: 10.1136/bcr-2019-229719
|
26 |
El Beltagi A , Abdelhady M , Barakat N , Alkailani Y Jr , Aboughalia H . Vogt-Koyanagi-Harada disease: a case report with distinct brain MRI enhancement patterns. Cureus, 2020, 12: e10391.
|
27 |
Manor RS , Livni E , Cohen S . Cell mediated immunity to human myelin basic protein in Vogt-Koyahagi-Harada syndrome. Invest Ophthalmol Vis Sci, 1979, 18: 204- 206.
|
28 |
Kato Y , Kurimura M , Yahata Y , Tajima K , Kato T . Vogt-Koyanagi-Harada's disease presenting polymorphonuclear pleocytosis in the cerebrospinal fluid at the early active stage. Intern Med, 2006, 45: 779- 781.
|
29 |
Mekkawy MO , Fouad YA , Nowara M , Aziz IA . Clinical and multimodal imaging characteristics of eyes with Vogt-Koyanagi-Harada disease: an Egyptian experience. Oman J Ophthalmol, 2023, 16: 88- 93.
|
30 |
Lubin JR , Loewenstein JI , Frederick AR Jr . Vogt-Koyanagi-Harada syndrome with focal neurologic signs. Am J Ophthalmol, 1981, 91: 332- 341.
|
31 |
Nakamura S , Nakazawa M , Yoshioka M , Nagano I , Nakamura H , Onodera J , Tamai M . Melanin-laden macrophages in cerebrospinal fluid in Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol, 1996, 114: 1184- 1188.
|
32 |
Takeshita T , Nakazawa M , Murakami K , Tamai M , Nakamura S . A patient with long standing melanin laden macrophages in cerebrospinal fluid in Vogt-Koyanagi-Harada syndrome. Br J Ophthalmol, 1997, 81: 1114.
|
33 |
Kamondi A , Szegedi A , Papp A , Seres A , Szirmai I . Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis. Eur J Neurol, 2000, 7: 719- 722.
|
34 |
Ono T , Goto H , Sakai T , Nitta F , Mizuki N , Takase H , Kaneko Y , Hori J , Nakano S , Nao-I N , Ohguro N , Miyata K , Tomita M , Mochizuki M , Japan VKH Disease Treatment Study Group . Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol, 2022, 66: 119- 129.
|
35 |
Papasavvas I , Tugal-Tutkun I , Herbort CP Jr . Vogt-Koyanagi-Harada is a curable autoimmune disease: early diagnosis and immediate dual steroidal and non-steroidal immunosuppression are crucial prerequisites. J Curr Ophthalmol, 2020, 32: 310- 314.
|
36 |
Miyanaga M , Kawaguchi T , Shimizu K , Miyata K , Mochizuki M . Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease. Int Ophthalmol, 2007, 27 (2/3): 183- 188.
|
37 |
Nakai S , Takeuchi M , Usui Y , Namba K , Suzuki K , Harada Y , Kusuhara S , Kaburaki T , Tanaka R , Takeuchi M , Mizuki N , Nakai K , Goto H , Herbort CP Jr . Efficacy and safety of adalimumab for exacerbation or relapse of ocular inflammation in patients with Vogt-Koyanagi-Harada disease: a multicenter study. Ocul Immunol Inflamm, 2022,
|